Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

scientific article published on 24 October 2017

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/ANNONC/MDX684
P698PubMed publication ID29077846

P50authorKoji IzutsuQ73006741
Ritsuro SuzukiQ73090383
Eric TseQ73119972
P2093author name stringS J Kim
S S Chuang
Y S Lee
W S Kim
Y L Kwong
N Schmitz
S Y Oh
C Suh
H J Shin
S R Lee
S T Lim
F d'Amore
Y R Do
A Jaccard
H S Eom
J Y Kwak
T Relander
Y C Mun
P433issue1
P921main subjectchemoradiotherapyQ5090613
P304page(s)256-263
P577publication date2017-10-24
P1433published inAnnals of OncologyQ326122
P1476titleSequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
P478volume29

Reverse relations

cites work (P2860)
Q55283069A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Q90510592Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)
Q64269086Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
Q97557982First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Q49721392NK/T Cell Lymphoma: Updates in Therapy
Q47548002Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas
Q99564958Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Q64081516Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
Q90171240Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Q92675485What we should know about natural killer/T-cell lymphomas

Search more.